
    
      BERTHA is a multicentric, observational study that will enroll 100 RA-ILD patients to be
      followed for 2 years.

      Interstitial Lung Disease (ILD) progression will be ascertained by quantitative image
      analysis and functional parameters. Variables associated with progression with be identified.

      Additionally, RA-ILD endotypes will be investigated as well as their association with RA-ILD
      progression.
    
  